The 2nd EHS for Biopharma East Summit is an essential event for EHS professionals working in the biopharma industry, focused ...

In Part 3 of our Life Sciences Industry Report 2025, we share content from the last twelve months that delved into the ...

The FDA has banned the use of a synthetic red dye used in oral medicines, as well as foods and dietary supplements, more than ...

Looking ahead to 2025, small biopharma will continue its deliberate and ROI-driven approach to technology adoption. At the ...

When healthcare brands leverage data to genuinely understand and connect with HCPs as unique individuals, the result is a ...

Generative artificial intelligence (genAI) player Bioptimus has swelled its coffers with another financing round, raising $41 ...

Santhera Pharmaceuticals will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks, after ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's ...